← Back to Search

Orthopedic Device

Atlas(TM) Knee System for Osteoarthritis (Atlas-USA Trial)

N/A
Waitlist Available
Research Sponsored by Moximed
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change at 24 months relative to baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the Atlas Knee System, a knee implant, in adults aged 25-80 with medial knee arthritis and significant pain. The device aims to support the knee joint and reduce pain. The Atlas Knee System was designed to fill the gap between ineffective conservative treatments and invasive surgery for young patients with medial knee osteoarthritis.

Eligible Conditions
  • Osteoarthritis of the Knee
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change at 24 months relative to baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and change at 24 months relative to baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood coagulation tests

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InvestigationalExperimental Treatment1 Intervention
Intervention - Atlas Knee System device for medial knee osteoarthritis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Atlas(TM) Knee System
2016
N/A
~50

Find a Location

Who is running the clinical trial?

MoximedLead Sponsor
6 Previous Clinical Trials
605 Total Patients Enrolled
5 Trials studying Osteoarthritis
282 Patients Enrolled for Osteoarthritis
Rose WeinsteinStudy DirectorMoximed
1 Previous Clinical Trials
81 Total Patients Enrolled
1 Trials studying Osteoarthritis
81 Patients Enrolled for Osteoarthritis
~6 spots leftby Nov 2025